Why the study?
The study aimed to investigate whether biomarkers reflecting the neurohormonal response, inflammation, and troponin add prognostic value to the TIMI risk score in STEMI patients.
Do neurohormonal and inflammatory biomarkers add prognostic value to the TIMI risk score for 30-day mortality in STEMI patients?
Do neurohormonal and inflammatory biomarkers add prognostic value to the TIMI risk score for 30-day mortality in STEMI patients?
MR-proADM alone is a stronger predictor of 30-day mortality in STEMI patients than the TIMI risk score or the TIMI risk score combined with other biomarkers.
Answers are grounded in this paper and cite their sources.
May enhance STEMI risk stratification; leaves open whether it improves clinical decisions beyond TIMI score.
BACKGROUND: The Thrombolysis in Myocardial Infarction (TIMI) risk score estimates mortality for patients with ST-elevation myocardial infarction (STEMI). This study aimed to investigate whether biomarkers reflecting the neurohormonal response (pro-atrial natriuretic peptide (proANP), mid-regional pro-adrenomedullin (MR-proADM), and copeptin), inflammation (suppression of tumorigenicity 2 (ST2), C-reactive protein (CRP), and leukocytes), and troponin add prognostic value to the TIMI risk score. METHODS: This sub-study of the prospective PREDICT cohort included 1700 non-comatose and non-cardiogenic shock STEMI patients upon admission. Blood samples were collected before coronary angiography. Biomarker quartiles (Q4vsQ1-3) association with 30-day mortality were examined using Cox proportional hazard models. RESULTS: (95%CI), MR-proADM: 8.8 (3.9-20), proANP: 3.5 (1.8-6.7), copeptin: 1.9 (1.1-3.5), ST2: 4.5 (2.3-8.6), CRP: 2.6 (1.3-4.9), and leukocyte: 2.18 (1.2;4.0). TIMI risk score had a high prognostic value, AUC(95%CI): 0.76 (0.69-0.83). Only MR-proADM, proANP, CRP, ST2, and TnT added prognostic value to the risk score, 0.84 (0.77-0.91), 0.80 (0.74-0.87), 0.78 (0.71-0.86), 0.81 (0.73-0.88), and 0.79 (0.71-0.87), respectively. However, MR-proADM demonstrated a higher prognostic value on its own (0.86 (0.80-0.91)). CONCLUSION: TIMI risk score and all the biomarkers added prognostic values of 30-day mortality. The strongest predictor of 30-day mortality was observed for MR-proADM alone.
No takes yet. Share an insight, caveat, or question.
Holle et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: